Literature DB >> 19008217

SUMOylation and De-SUMOylation: wrestling with life's processes.

Edward T H Yeh1.   

Abstract

The small ubiquitin-like modifier (SUMO) is a ubiquitin-like protein that covalently modifies a large number of cellular proteins. SUMO modification has emerged as an important regulatory mechanism for protein function and localization. SUMOylation is a dynamic process that is mediated by activating (E1), conjugating (E2), and ligating (E3) enzymes and readily reversed by a family of ubiquitin-like protein-specific proteases (Ulp) in yeast and sentrin/SUMO-specific proteases (SENP) in human. This review will focus on the de-SUMOylating enzymes with special attention to their biological function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008217      PMCID: PMC2659178          DOI: 10.1074/jbc.R800050200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Differential regulation of sentrinized proteins by a novel sentrin-specific protease.

Authors:  L Gong; S Millas; G G Maul; E T Yeh
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs.

Authors:  K I Kim; S H Baek; Y J Jeon; S Nishimori; T Suzuki; S Uchida; N Shimbara; H Saitoh; K Tanaka; C H Chung
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

Review 3.  Ubiquitin-like proteins: new wines in new bottles.

Authors:  E T Yeh; L Gong; T Kamitani
Journal:  Gene       Date:  2000-05-02       Impact factor: 3.688

4.  Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.

Authors:  E Mossessova; C D Lima
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

5.  Basic Medical Research Award. The ubiquitin system.

Authors:  A Hershko; A Ciechanover; A Varshavsky
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

6.  A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase.

Authors:  T Nishida; H Tanaka; H Yasuda
Journal:  Eur J Biochem       Date:  2000-11

7.  An E3-like factor that promotes SUMO conjugation to the yeast septins.

Authors:  E S Johnson; A A Gupta
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

8.  Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

Authors:  H Poukka; U Karvonen; O A Janne; J J Palvimo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53.

Authors:  T Kahyo; T Nishida; H Yasuda
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

10.  The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity.

Authors:  Shyr-Jiann Li; Mark Hochstrasser
Journal:  J Cell Biol       Date:  2003-03-24       Impact factor: 10.539

View more
  214 in total

1.  An in vitro Förster resonance energy transfer-based high-throughput screening assay for inhibitors of protein-protein interactions in SUMOylation pathway.

Authors:  Yang Song; Jiayu Liao
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

Review 2.  Trojan horse strategies used by pathogens to influence the small ubiquitin-like modifier (SUMO) system of host eukaryotic cells.

Authors:  Miklós Békés; Marcin Drag
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

3.  Expanding NFκB and SUMO ties.

Authors:  Moon-Hee Lee; Shigeki Miyamoto
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

4.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

5.  Cardiovascular biology: heart fails without pump partner.

Authors:  Sudha K Shenoy; Howard A Rockman
Journal:  Nature       Date:  2011-09-28       Impact factor: 49.962

6.  PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy.

Authors:  Samisubbu R Naidu; Alexander J Lakhter; Elliot J Androphy
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

7.  De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.

Authors:  Kyung-Sun Heo; Eugene Chang; Nhat-Tu Le; Hannah Cushman; Edward T H Yeh; Keigi Fujiwara; Jun-ichi Abe
Journal:  Circ Res       Date:  2013-02-04       Impact factor: 17.367

8.  Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.

Authors:  Mourad Ferdaoussi; Xiaoqing Dai; Mette V Jensen; Runsheng Wang; Brett S Peterson; Chao Huang; Olga Ilkayeva; Nancy Smith; Nathanael Miller; Catherine Hajmrle; Aliya F Spigelman; Robert C Wright; Gregory Plummer; Kunimasa Suzuki; James P Mackay; Martijn van de Bunt; Anna L Gloyn; Terence E Ryan; Lisa D Norquay; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Richard G Kibbey; Jocelyn E Manning Fox; William F Colmers; Orian S Shirihai; P Darrell Neufer; Edward T H Yeh; Christopher B Newgard; Patrick E MacDonald
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

9.  SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.

Authors:  Seong Won Lee; Moon Hee Lee; Jong Ho Park; Sung Hwan Kang; Hee Min Yoo; Seung Hyun Ka; Young Mi Oh; Young Joo Jeon; Chin Ha Chung
Journal:  EMBO J       Date:  2012-10-23       Impact factor: 11.598

10.  The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.

Authors:  Haoxun Wang; Guofeng You
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-05-01       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.